Michael F MacLean insider trades
Open-market stock purchases and sales by Michael F MacLean, Director at Camp4 Therapeutics Corp, from SEC Form 4 filings since Jan 19, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 1, 2026 | CAMP Camp4 Therapeutics Corp | Bought (not open market) | — |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc | Sold (not open market) | — |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc | Sold (not open market) | $2.1M |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc | Sold (not open market) | $1.9M |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc | Sold (not open market) | $3.3M |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc | Sold (not open market) | $395K |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc | Sold (not open market) | $1.1M |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc | Sold (not open market) | $1.6M |
| Jan 21, 2026 | RNA Avidity Biosciences, Inc | Sold | $131K |
| Jan 21, 2026 | RNA Avidity Biosciences, Inc | Sold | $198K |
| Jan 7, 2026 | RNA Avidity Biosciences, Inc | Sold | $143K |
Companies traded
- CAMP Camp4 Therapeutics Corp: other filings, last Apr 1, 2026
- RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026
- RNA Avidity Biosciences, Inc: 17 sales, last Jan 21, 2026
- VERV Verve Therapeutics, Inc: other filings, last Jul 25, 2025
- AKCA Akcea Therapeutics, Inc: other filings, last Jan 15, 2020
- BIIB Biogen Idec Inc: 10 sales, last Oct 1, 2010